Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • TRTL-107

Tag: TRTL-107

Graphic: obuprazine schizophrenia clinical trial, three capsule shapes for each dose range with placebo-adjusted PANSS changes
  • Pharmaceuticals

Tortugas’ Obuprazine Beats Placebo in Phase 2b Schizophrenia Study

Megan Wood2 hours ago1 hour ago011 mins

Tortugas reports obuprazine beat placebo at all doses in a 363-patient Phase 2b. Five claims checked against the evidence, plus what is still missing.

Read More

Categories

  • Healthcare IT (14)
  • Industry Insights (298)
  • Lifestyle and Wellness (21)
  • Medical Devices (24)
  • Pharmaceuticals (45)
  • Uncategorized (1)

Recent Posts

  • FDA Backs Proposed Stem Cell Trial for Treatment-Resistant Crohn’s Disease
  • Lasix ONYU Home Study: 18 of 21 Heart Failure Patients Avoided Admission
  • Castle Biosciences Data Show Barrett’s Risk Test Shifts Surveillance Plans
  • Envoy’s Fully Implanted Cochlear Implant Files Second FDA Module
  • Sun Pharma Board Caps Debenture Raise at ₹10,000 Crore
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.